Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients: A Propensity Score…

Overview of attention for article published in Cardiovascular Drugs and Therapy, February 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

twitter: 4 X users

guideline: 1 clinical guideline source

Readers on

mendeley: 25 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,244 followers.

Open Access UCL Research: Comparison of sodium glucose cotransporter-2 inhibitor and dipeptidyl peptidase-4 inhibitor on the risk of new-onset atrial fibrillation, stroke and mortality in diabetic patients... https://t.co/egF9UCd0Cx

Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients: A Propensity Score-Matched Study in Hong Kong https://t.co/wlfHV8pEID

RT @cvanalytics2015: Our team conducted a propensity-score matched population-based study comparing the risks of new onset atrial fibrillat…

Our team conducted a propensity-score matched population-based study comparing the risks of new onset atrial fibrillation and stroke between SGLT2i and DPP4i users Published in Cardiovasc Drugs Ther (2022). https://t.co/QvSZEnPsLb @JdongZhou @sharen21…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.